Basic information Application Safety Supplier Related

6-(tert-butoxycarbonyl)-6-azaspiro[2.5]octane-1-carboxylic acid

Basic information Application Safety Supplier Related

6-(tert-butoxycarbonyl)-6-azaspiro[2.5]octane-1-carboxylic acid Basic information

Product Name:
6-(tert-butoxycarbonyl)-6-azaspiro[2.5]octane-1-carboxylic acid
Synonyms:
  • 6-(tert-butoxycarbonyl)-6-azaspiro[2.5]octane-1-carboxylic acid(SALTDATA: FREE)
  • 3. 6-[(tert-Butoxy)carbonyl]-6-a7.aspiro[2 5]octane- l -carboxyl ic acid
  • 6-Boc-6-azaspiro[2.5]octane-1-carboxylic Acid
  • 6-Azaspiro[2.5]octane-1,6-dicarboxylic acid, 6-(1,1-dimethylethyl) ester
  • 6-azaspiro[2.5]octane-1-carboxylic acid
  • 6-(tert-butoxycarbonyl)-6-azaspiro[2.5]octane-1,6-dicarboxylic acid
  • 6-[(2-methylpropan-2-yl)oxycarbonyl]-6-azaspiro[2.5]octane-2-carboxylic acid
  • 6-(tert-butoxycarbonyl)-6-azaspiro 2.5 octane-1-carboxylic acid(SALTDATA
CAS:
871727-05-8
MF:
C13H21NO4
MW:
255.31
Mol File:
871727-05-8.mol
More
Less

6-(tert-butoxycarbonyl)-6-azaspiro[2.5]octane-1-carboxylic acid Chemical Properties

Boiling point:
392.1±35.0 °C(Predicted)
Density 
1.20±0.1 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
pka
4.71±0.20(Predicted)
form 
solid
color 
White to off-white
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36
Safety Statements 
26
WGK Germany 
3
HS Code 
2916399090
More
Less

6-(tert-butoxycarbonyl)-6-azaspiro[2.5]octane-1-carboxylic acid Usage And Synthesis

Application

6-BOC-6-azaspiro[2.5]octane-1-carboxylic acid is an important pharmaceutical intermediate and a key raw material for the synthesis of many drugs and excipients. It is used in the preparation of tyrosine kinases and some protein kinase inhibitors.

Synthesis

1242268-17-2

871727-05-8

Step 3: 6-tert-butyl 1-ethyl 6-azaspiro[2.5]octane-1,6-dicarboxylate (500 mg, 1.76 mmol) was dissolved in ethanol (8 mL) and a solution of sodium hydroxide (212 mg, 5.3 mmol) in water (4 mL) was added. The reaction mixture was stirred at 15°C for 12 hours. After completion of the reaction, the solvent was removed by evaporation under reduced pressure. The residue was dissolved in water and slowly acidified with dilute hydrochloric acid (0.5 M) under cooling in an ice bath to pH ~ 4. The aqueous phase was extracted with ethyl acetate (10 mL x 3). The organic phases were combined, dried with anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give 6-(tert-butoxycarbonyl)-6-azaspiro[2.5]octane-1-carboxylic acid (390 mg, 83% yield) as a white solid.1H NMR (400 MHz, CDCl3): δ 3.52-3.42 (m, 3H), 3.38-3.35 (m, 1H), 1.75- 1.72 (m, 2H), 1.58-1.56 (m, 1H), 1.46-1.43 (m, 11H), 1.23-1.21 (m, 1H), 1.02-1.01 (m, 1H).

References

[1] Patent: WO2015/949, 2015, A1. Location in patent: Page/Page column 117-118
[2] Patent: WO2013/127269, 2013, A1. Location in patent: Page/Page column 189; 190

6-(tert-butoxycarbonyl)-6-azaspiro[2.5]octane-1-carboxylic acidSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Syntechem Co.,Ltd
Tel
Email
info@syntechem.com
Nanjing ShengSai Chemical Co., Ltd.
Tel
025-85205967 13951876367
Email
shengsaichem@163.com
Bide Pharmatech Ltd.
Tel
400-164-7117 13681763483
Email
product02@bidepharm.com
Nantong MYBio-pharm. Co., Ltd.
Tel
0513-85921823 18662920231
Email
sales@ntminyanmedical.com